Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020
-
Mónica Pérez-Ríos [1] ; Diana Carolina López-Medina [1] ; Carla Guerra-Tort [1] ; Julia Rey-Brandariz [1] ; Leonor Varela-Lema [1] ; María Isolina Santiago-Pérez [2] ; Cristina Candal [1] ; Agustin Montes [1] ; María José López [6] ; Regina Dalmau [3] ; Maraino Provencio [4] ; Esteve Fernández [5] ; Ana Blanco [1] ; Alberto Ruano-Ravina [1]
-
[1] Universidade de Santiago de Compostela
Universidade de Santiago de Compostela
Santiago de Compostela, España
-
[2] Xunta de Galicia
Xunta de Galicia
Santiago de Compostela, España
-
[3] Hospital Universitario La Paz
Hospital Universitario La Paz
Madrid, España
-
[4] Hospital Universitario Puerta de Hierro
Hospital Universitario Puerta de Hierro
Madrid, España
-
[5] Institute Catalá Oncología
Institute Catalá Oncología
Barcelona, España
-
[6] Servicio de Evaluación y Métodos de Intervención, Agència de Salut Pública de Barcelona, Spain
-
- Localización: Archivos de bronconeumología: Organo oficial de la Sociedad Española de Neumología y Cirugía Torácica SEPAR y la Asociación Latinoamericana de Tórax ( ALAT ), ISSN 0300-2896, Vol. 59, Nº. 5, 2023, págs. 305-310
- Idioma: inglés
- Enlaces
- Dialnet Métricas: 2 Citas
-
Resumen
Introduction and objectives Exposure to environmental tobacco smoke (ETS) is associated with increased mortality and morbidity. The objective of this study was to estimate the impact of ETS exposure in Spain on mortality in 2020 in the population aged 35 years and over.
Methods A method of estimating attributable mortality (AM) based on the prevalence of ETS exposure was applied. Prevalence data were obtained from a representative study conducted in Spain and the relative risks were derived from a meta-analysis. AM point estimates are presented along with 95% confidence intervals (95% CI), calculated using a bootstrap naive procedure. AM, both overall and by smoking habit, was estimated for each combination of sex, age group, and cause of death (lung cancer and ischemic heart disease). A sensitivity analysis was performed.
Results A total of 747 (95% CI 676–825) deaths were attributable to ETS exposure, of which 279 (95% CI 256–306) were caused by lung cancer, and 468 (95% CI 417–523) by ischemic heart disease. Three-quarters (75.1%) of AM occurred in men and 60.9% in non-smokers. When chronic obstructive pulmonary disease and cerebrovascular disease are included, the burden of AM is estimated at 2242 deaths.
Conclusions ETS exposure is associated with 1.5% of all deaths from lung cancer and ischemic heart disease in the population aged 35 and over. These data underline the need for health authorities to focus on reducing exposure to ETS in all settings and environments.
